Black Rock Inc. Vaxcyte, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,939,846 shares of PCVX stock, worth $860 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,939,846

Previous 9,513,007 4.49%

Holding current value

$860 Million

Previous $650 Million 15.5%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$60.06 - $78.77 $25.6 Million - $33.6 Million	426,839 Added 4.49%	9,939,846 $751 Million
Q1 2024 May 10, 2024	BUY	$59.79 - $81.05 $56 Million - $76 Million	937,160 Added 10.93%	9,513,007 $650 Million
Q4 2023 Feb 13, 2024	BUY	$45.35 - $63.41 $52.4 Million - $73.2 Million	1,154,596 Added 15.56%	8,575,847 $539 Million
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $16.4 Million - $18.9 Million	356,163 Added 5.04%	7,421,251 $378 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $68.7 Million - $107 Million	1,983,223 Added 39.03%	7,065,088 $353 Million
Q1 2023 May 12, 2023	SELL	$36.27 - $47.2 $852,526 - $1.11 Million	-23,505 Reduced 0.46%	5,081,865 $190 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $33.2 Million - $77.3 Million	1,613,049 Added 46.19%	5,105,370 $245 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $4.79 Million - $6.3 Million	220,691 Added 6.75%	3,492,321 $83.8 Million
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $6.82 Million - $10.2 Million	385,608 Added 13.36%	3,271,630 $71.2 Million
Q1 2022 May 12, 2022	BUY	$17.46 - $26.36 $1.9 Million - $2.87 Million	108,975 Added 3.92%	2,886,022 $69.7 Million
Q4 2021 Feb 10, 2022	BUY	$19.32 - $26.45 $4.88 Million - $6.68 Million	252,402 Added 10.0%	2,777,047 $66.1 Million
Q3 2021 Nov 09, 2021	BUY	$20.26 - $26.97 $3.61 Million - $4.8 Million	178,028 Added 7.59%	2,524,645 $64.1 Million
Q2 2021 Aug 11, 2021	BUY	$16.45 - $24.06 $38.6 Million - $56.5 Million	2,346,617 New	2,346,617 $52.8 Million

Others Institutions Holding PCVX

# of Institutions

351

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.13B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account